Allarity Therapeutics, Inc. (ALLR) has provided an announcement.
Allarity Therapeutics, Inc. streamlined its capital structure by converting all outstanding Series A Preferred Stock into common stock and converting 93% of its warrants, leaving only a few unexercised. The company also announced the full repayment of all bridge notes, including principal and interest, marking a significant financial restructuring aimed at simplifying the company’s share classification and reducing debt.
See more data about ALLR stock on TipRanks’ Stock Analysis page.
